[Diagnosis and therapy of micromolecular plasmocytomas -- a case report].
It is reported on the symptomatology, diagnostics and therapy in a 54-year-old patient with a micromolecular plasmocytoma of kappa-type. Here particularly the impressionable improvement of the clinical picture after an intermitting impact therapy with melphalan (alkeran) - prednisolone in a period of treatment of approximately 2 years is emphasized.
D001536:Bence Jones Protein / Q000652:urine; D006801:Humans; D007145:Immunoglobulin kappa-Chains / Q000652:urine; D008159:Lumbar Vertebrae / Q000000981:diagnostic imaging; D008297:Male; D008558:Melphalan / Q000627:therapeutic use; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010014:Osteolysis / Q000209:etiology; D010954:Plasmacytoma / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy; D011239:Prednisolone / Q000627:therapeutic use; D011859:Radiography
D007145:Immunoglobulin kappa-Chains; D001536:Bence Jones Protein; D011239:Prednisolone; D008558:Melphalan
Zur Diagnostik und Therapie des mikromolekularen Plasmozytoms--ein kasuistischer Beitrag.